05:33 PM EDT, 10/10/2024 (MT Newswires) -- Lifecore Biomedical ( LFCR ) filed a registration statement with the US Securities and Exchange Commission Thursday covering the potential resale of up to about 6.8 million common shares from time to time by certain shareholders.
The company said it will not receive any proceeds from the share sale.